3D Systems, a leading company in 3D printing technologies, has recently partnered with the Israeli bioprinting firm CollPlant to generate artificial tissues and scaffolds.

 .

This collaboration will allow the two to combine their technologies in the 3D printing space, specifically the physical printers from 3D Systems and CollPlant’s proprietary recombinant human collagen (rhCollagen), which is a bioink used to 3D print organic tissues.

 .

“3D Systems is excited to work with CollPlant to develop groundbreaking bioprinted tissue and scaffold technologies,” explained Chuck Hull, co-founder, and chief technology officer of 3D Systems. “We believe 3D printing to be a key technology for regenerative medicine, and this collaboration is one of many we are entering to play an integral role in this exciting field. Combining our innovative 3D printing technologies with CollPlant’s rhCollagen based bioinks has the potential to make a significant impact in bioprinting and regenerative medicine.”

 .

CollPlant emphasizes its work on regenerative medicine, with its unique rhCollagen acting as a 3D printing substrate. This bioink functions as a support system for human stem cells, which can flourish and contribute to the artificial tissue. The rhCollagen is derived from genetically engineered tobacco plants, making it a plant-based solution.

Click here to view original web page at www.docwirenews.com